BioTime, Inc. Announces the Appointment of Life Sciences Industry Veteran Russell Skibsted as Chief Financial Officer

ALAMEDA, Calif. -- BioTime, Inc. (NYSE MKT and TASE: BTX), a clinical-stage regenerative medicine company with a focus on pluripotent stem cell technology, today announced that the Company’s Board of Directors has appointed Russell Skibsted to the position of Chief Financial Officer, succeeding Robert Peabody. Mr. Russell Skibsted brings over 25 years of financial management [...]

EM Resolutions: New TEM grids for FIB lift-out procedures

Saffron Walden, UK: EM Resolutions, manufacturers and suppliers of tools and accessories for users of electron microscopes, announce the availability of EM-Tec FIB grids which offer a secure way to attach TEM lamellas to the posts during lift-out procedures with FIB or SEM/FIB systems. The new EM-Tec range of FIB lift-out grids from EM Resolutions [...]

Merck KGaA Completes $17B Sigma-Aldrich Acquisition

NEW YORK – Germany's Merck KGaA today announced the completion of its $17 billion acquisition of Sigma-Aldrich, following approval from the European Commission. The deal creates a science sector giant that will "cover every step of the biotech production chain," Merck said in a statement. The company will have around 50,000 employees in 67 countries, [...]

PARIS & RADNOR, Pa. -- Air Liquide (Euronext Paris:AI), world leader in gases, technologies and services for Industry and Health, and Airgas (NYSE:ARG), one of the leading suppliers of industrial gases and associated products and services in the U.S., today announced an agreement under which Air Liquide will acquire Airgas. Airgas shareholders will receive $143 [...]

Kymab Implements Genedata Biologics for High-throughput Antibody Discovery

Basel, Switzerland -- Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that Kymab Ltd. has licensed Genedata Biologics™ for use in their proprietary antibody discovery programs. The platform will support biopharma R&D operations from early B-cell and hybridoma screening, to antibody engineering, expression, purification, and analytics. [...]

Enzo Biochem Announces New York State Approval of Its First Assay Based on Ampiprobe™ Platform Aimed at Providing Affordable Molecular Diagnostics in Light of Reimbursement Pressure

NEW YORK, NY – Enzo Biochem, Inc. (NYSE: ENZ) announced that the New York State Department of Health has granted approval of Enzo Clinical Labs’ AmpiProbe-HCV ™ assay for the quantitative detection of Hepatitis C virus, clearing the way for Enzo to begin offering this assay to the market on a national basis. In addition, [...]

Tektronix Unveils Cost-Effective, Versatile Electrochemistry Lab Systems New Solution Lowers Instrumentation Costs; Makes Running Lab Experiments Faster, Easie

BEAVERTON, Ore. -- Tektronix, Inc., a leading worldwide provider of test, measurement and monitoring instrumentation, announced the industry's first graphical touchscreen Electrochemistry Lab Systems, the 2450-EC and 2460-EC. These new Keithley interactive solutions offer a lower cost, more flexible, and easier method for conducting a range of electrochemistry experiments, including cyclic voltammetry, chronoamperometry, and chronopotentiometry. [...]

Funds Used to Eliminate Additional Variable Rate Convertible Debt, Design and Build Initial Prototype of Next Generation PCT-HD System, and Expand Product Manufacturing Capacity to Support Expected Continuing Sales Ramp in Q4 2015 and Beyond

SOUTH EASTON, Mass. -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced it has received gross proceeds of $745,000 from an additional closing of its $5 million Private Placement [...]

N-of-One Selected by WuXi NextCODE for Global Relationship, to Provide Clinical and Scientific Evidence for Interpretation for Cancer

LEXINGTON, Mass. – N-of-One, Inc., the leader in clinical interpretation for precision medicine in oncology, today announced that it has signed a global agreement with WuXi NextCODE to provide clinical and scientific evidence for delivering the best personalized treatment options based on the results of WuXi NextCODE tumor-normal genome sequence interpretation, which identifies key driver [...]

The Chemistry Department of Virginia Commonwealth University use Magritek’s Spinsolve benchtop NMR for undergraduate teaching

Aachen, Germany: Magritek, a leading provider of compact NMR and MRI instruments, report on the use of their Spinsolve Benchtop NMR spectrometer in the Chemistry Department of Virginia Commonwealth University. It is being used in the undergraduate teaching program under the supervision of Ms Meredith Moses. Ms Lucy (Meredith) Moses is a member of the [...]

Access IBO on Knowledge Center